This inventor holds 1 USPTO granted patent. Top assignees: Universidade Da Beira Interior, Universidade De Aveiro. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2026
Title: Dina Batista Pereira: Innovator in Neurological Disease Treatment
Introduction
Dina Batista Pereira is a prominent inventor based in Covilhã, Portugal. She has made significant contributions to the field of neurological disease treatment through her innovative research and patenting efforts. Her work focuses on developing formulations that can potentially prevent or treat neurological disorders, particularly Parkinson's disease.
Latest Patents
Dina holds a patent for her invention titled "Ionic-liquid-based formulations for the prevention or treatment of neurological diseases." This patent describes an ionic liquid (IL)-based formulation that includes inhibitors of NADPH oxidase enzymes, specifically targeting isoforms 1 and 4. The formulation features the specific inhibitor 3-cyclohexyl-5-(2,4-dihydroxybenzylidene)-1-methyl-2-thiohydantoin, which is aimed at providing therapeutic benefits for individuals suffering from neurological diseases.
Career Highlights
Throughout her career, Dina has worked with esteemed institutions such as the University of Aveiro and the University of Beira Interior. Her academic and research endeavors have positioned her as a key figure in the study of neurological disorders and their treatments.
Collaborations
Dina has collaborated with notable colleagues, including João Manuel Costa Araújo Pereira Coutinho and Mukesh Sharma. These partnerships have further enriched her research and contributed to the advancement of her innovative work.
Conclusion
Dina Batista Pereira's contributions to the field of neurological disease treatment through her patent and collaborations highlight her dedication to innovation and research. Her work has the potential to make a significant impact on the lives of those affected by neurological disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile